TY - JOUR
T1 - Development of a Polymer-Based Biodegradable Neurovascular Stent Prototype
T2 - A Preliminary In Vitro and In Vivo Study
AU - Nikoubashman, Omid
AU - Heringer, Sarah
AU - Feher, Katalin
AU - Brockmann, Marc-Alexander
AU - Sellhaus, Bernd
AU - Dreser, Alice
AU - Kurtenbach, Kathrin
AU - Pjontek, Rastislav
AU - Jockenhoevel, Stefan
AU - Weis, Joachim
AU - Kiessling, Fabian
AU - Gries, Thomas
AU - Wiesmann, Martin
PY - 2018/7
Y1 - 2018/7
N2 - Biodegradable stents are not established in neurovascular interventions. In this study, mechanical, radiological, and histological characteristics of a stent prototype developed for neurovascular use are presented. The elasticity and brittleness of PLA 96/4, PLDL 70/30, PCL, and PLGA 85/15 and 10/90 polymers in in vitro experiments are first analyzed. After excluding the inapt polymers, degradability and mechanical characteristics of 78 PLGA 85/15 and PLGA 10/90 stent prototypes are analyzed. After excluding PLGA 10/90 stents because of rapid loss of mass PLGA 85/15 stents in porcine in vivo experiments are analyzed. Angiographic occlusion rates 7 d, 1 month, 3 months, and 6 months after stent implantation are assessed. Histological outcome measures are the presence of signs of inflammation, endothelialization, and the homogeneity of degradation after six months. One case of stent occlusion occurs within the first 7 d. There is a prominent foreign-body reaction with considerable mononuclear and minor granulocytic inflammation combined with incomplete fragmental degradation of the struts. It is possible to produce a stent prototype with dimensions that fit the typical size of carotid arteries. Major improvements concerning thrombogenicity, degradation, and inflammatory response are required to produce biodegradable stents that are suitable for neurovascular interventions.
AB - Biodegradable stents are not established in neurovascular interventions. In this study, mechanical, radiological, and histological characteristics of a stent prototype developed for neurovascular use are presented. The elasticity and brittleness of PLA 96/4, PLDL 70/30, PCL, and PLGA 85/15 and 10/90 polymers in in vitro experiments are first analyzed. After excluding the inapt polymers, degradability and mechanical characteristics of 78 PLGA 85/15 and PLGA 10/90 stent prototypes are analyzed. After excluding PLGA 10/90 stents because of rapid loss of mass PLGA 85/15 stents in porcine in vivo experiments are analyzed. Angiographic occlusion rates 7 d, 1 month, 3 months, and 6 months after stent implantation are assessed. Histological outcome measures are the presence of signs of inflammation, endothelialization, and the homogeneity of degradation after six months. One case of stent occlusion occurs within the first 7 d. There is a prominent foreign-body reaction with considerable mononuclear and minor granulocytic inflammation combined with incomplete fragmental degradation of the struts. It is possible to produce a stent prototype with dimensions that fit the typical size of carotid arteries. Major improvements concerning thrombogenicity, degradation, and inflammatory response are required to produce biodegradable stents that are suitable for neurovascular interventions.
KW - biodegradable polymers
KW - bioresorbable
KW - neurovascular
KW - PLGA
KW - stent
KW - DRUG-ELUTING STENTS
KW - BIORESORBABLE VASCULAR SCAFFOLDS
KW - OPTICAL COHERENCE TOMOGRAPHY
KW - FOLLOW-UP
KW - CORONARY
KW - ENDOTHELIALIZATION
KW - IMPLANTATION
KW - PARADIGM
KW - TRIAL
U2 - 10.1002/mabi.201700292
DO - 10.1002/mabi.201700292
M3 - Article
C2 - 29855168
SN - 1616-5187
VL - 18
JO - Macromolecular Bioscience
JF - Macromolecular Bioscience
IS - 7
M1 - 1700292
ER -